5360-04-3

Basic information

• Product Name: Methanol, (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-, diacetate
• Synonyms: (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-methano diacetate;(1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-methanodiacetate;1,3-bis(Acetoxymethyl)tetramethyldisiloxane;Methanol, (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-, diacetate;Methanol,(1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-,diacetate;(1,1,3,3-Tetramethylpropanedisiloxane-1,3-diyl)bismethanol diacetate
• CAS NO: 5360-04-3
• Molecular Formula: C₁₀H₂₂O₅Si₂
• Molecular Weight: 278.45
• EINECS: 226-345-9
• Mol File: 5360-04-3.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 235.3°Cat760mmHg
• Flash Point: 80°C
• Appearance: /
• Density: 1g/cm³
• Vapor Pressure: 0.0505mmHg at 25°C
• Refractive Index: 1.424
• CAS DataBase Reference: Methanol, (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-, diacetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methanol, (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-, diacetate(5360-04-3)
• EPA Substance Registry System: Methanol, (1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis-, diacetate(5360-04-3)

Safety Data

• Hazardous Substances Data: 5360-04-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H22O5Si2/c1-9(11)13-7-16(3,4)15-17(5,6)8-14-10(2)12/h7-8H2,1-6H3

Upstream product

• 17201-83-1 1-chloromethylpentamethyldisiloxane 
• 127-08-2 potassium acetate 
• 64-19-7 acetic acid 
• 2362-10-9 1,3-Bis(chloromethyl)-1,1,3,3-tetramethyldisiloxane 
• 2351-13-5 1,3-bis(bromomethyl)-1,1,3,3-tetramethyldisiloxane 
• 107-46-0 Hexamethyldisiloxane 

Downstream Products

• 79-20-9 acetic acid methyl ester 
• 541-05-9 Hexamethylcyclotrisiloxane 
• 18641-25-3 1,3-bis-(3,5-dinitro-benzoyloxymethyl)-1,1,3,3-tetramethyl-disiloxane 
• 5833-59-0 (1,1,3,3-tetramethyldisiloxane-1,3-diyl)dimethanol 

Relevant articles and documents

SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME

Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.